ArticleInternational journal of molecular sciences2020
Novel Phenothiazine-Bridged Porphyrin-(Hetero)aryl dyads: Synthesis, Optical Properties, In Vitro Cytotoxicity and Staining of Human Ovarian Tumor Cell Lines.
Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 11 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 1 country.
Eva MolnarThe Research Center on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos street, RO-400028 Cluj-Napoca, Romania.
Emese GalThe Research Center on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos street, RO-400028 Cluj-Napoca, Romania.
Luiza GainaThe Research Center on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos street, RO-400028 Cluj-Napoca, Romania.ORCID 0000-0001-8510-8472
Castelia CristeaThe Research Center on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos street, RO-400028 Cluj-Napoca, Romania.ORCID 0000-0003-1138-2596
Eva Fischer-FodorDepartment of Radiobiology and Tumor Biology, Institute of Oncology "Prof.Dr. Ion Chiricuta", 34-36 Republicii street, RO-400015 Cluj-Napoca, Romania.
Maria Perde-SchreplerDepartment of Radiobiology and Tumor Biology, Institute of Oncology "Prof.Dr. Ion Chiricuta", 34-36 Republicii street, RO-400015 Cluj-Napoca, Romania.ORCID 0000-0001-8581-0982
Patriciu Achimas-CadariuDepartment of Surgery, Institute of Oncology "Prof.Dr. Ion Chiricuta", 34-36 Republicii street, 400015 Cluj-Napoca, Romania.ORCID 0000-0001-9928-5883
Monica FocsanInstitute for Interdisciplinary Experimental Research in Bionanoscience, Nanobiophotonics Laboratory, Babeş-Bolyai University, 42 Laurian street, 400271 Cluj-Napoca, Romania.ORCID 0000-0001-6735-5146
Luminita Silaghi-DumitrescuThe Research Center on Fundamental and Applied Heterochemistry, Department of Chemistry, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos street, RO-400028 Cluj-Napoca, Romania.ORCID 0000-0001-8800-4839
Babeș-Bolyai University · ROIuliu Hațieganu University of Medicine and Pharmacy · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · RO
Funding
Romanian Ministry of Research and Innovation PN-III-P4-ID-PCCF-2016-0142
6 · The paper itself
Abstract
We report here the synthetic procedure applied for the preparation of new AB
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Novel Phenothiazine-Bridged Porphyrin-(Hetero)aryl dyads: Synthesis, Optical Properties, In Vitro Cytotoxicity and Staining of Human Ovarian Tumor Cell Lines. · full record | OpenQuestion